stage-specific sensitivity p53 restoration lung cancer progression
tumorigenesis multistep process results sequential accumulation mutations key oncogene tumour suppressor pathways personalized cancer therapy based targeting underlying genetic abnormalities presupposes sustained inactivation tumour suppressors activation oncogenes essential advanced cancers mutations p53 tumour-suppressor pathway common human cancer significant efforts towards pharmaceutical reactivation defective p53 pathways underway- show restoration p53 established murine lung tumours leads significant incomplete tumour cell loss specifically malignant adenocarcinomas adenomas define amplification mapk signalling critical determinant malignant progression also stimulator arf tumour-suppressor expression response p53 restoration context critically dependent expression arf propose p53 limits malignant progression suppressing acquisition alterations lead tumour progression also context p53 restoration responds increased oncogenic signalling mediate tumour regression observations also underscore p53 pathway engaged low levels oncogene activity sufficient early stages lung tumour development data suggest restoration pathways important tumour progression opposed initiation may lead incomplete tumour regression due stage-heterogeneity tumour cell populations
